Agilent Fiscal Q1 Revenues Rebound, Growing 4 Percent; Life Science Receipts Jump 10 Percent | GenomeWeb

By Tony Fong

A 10-percent jump in life science revenues helped Agilent Technologies grow total revenues for its fiscal first quarter 4 percent, the company said today.

The bounce was the first reported by the company in more than a year as its slumping Electronic Measurement business and the effects of the overall economic recession resulted in four consecutive quarters in which total revenues shrank.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.